A drug with the SMILES CN1Cc2c(N3CCOCC3)nc3sc(C#N)c(N)c3c2CC1(C)C has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -8.570%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CN1Cc2c(N3CCOCC3)nc3sc(C#N)c(N)c3c2CC1(C)C
CN1Cc2c(N3CCOCC3)nc3sc(C#N)c(N)c3c2CC1(C)C
1-amino-7,8,8-trimethyl-5-morpholin-4-yl-6,9-dihydrothieno[2,3-c][2,7]naphthyridine-2-carbonitrile